プロトロンビン複合体濃縮物の世界市場レポート 2025年

プロトロンビン複合体濃縮物市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.6%で、18億6,000万米ドルに成長する見込みです。予測期間中の成長は、迅速な凝固療法に対する需要の高まり、血友病や肝疾患の有病率の増加、救急医療における採用の増加、心臓手術における用途の拡大、ヘルスケア支出の増加などの要因によるものです。この期間の主な動向には、AI主導型診断の統合、遺伝子組換え凝固因子の進歩、次世代遺伝子組換えPCC、カスタマイズされた投与アルゴリズム、血漿製剤の進歩などがあります。

出血性疾患の有病率の増加は、今後数年間のプロトロンビン複合体濃縮物市場の拡大を促進すると予想されます。出血性疾患は、血液が適切に凝固せず、凝固因子や血小板の欠落や機能不全によって過剰な出血を引き起こす疾患です。出血性疾患の増加は主に、血友病などの遺伝性疾患の有病率の増加、肝疾患の症例の増加、抗凝固薬の広範な使用、ビタミンK欠乏症の割合の増加などに起因しています。プロトロンビン複合体濃縮物は、血液凝固および止血に不可欠な凝固因子を迅速に補充することで、出血性疾患の管理に役立ちます。例えば、2023年11月、米国を拠点とする医学図書館National Library of Medicineは、2022年に40カ国の87の治療センターで実施された研究を報告しました。この研究には1万276人の血友病患者が参加し、参加者の49％が重度の血友病でした。参加者の大部分（99％）は男性で、85％が血友病Aでした。さらに、患者の67％は低・中所得国の出身でした。このように、出血性疾患の有病率の増加はプロトロンビン複合体濃縮物市場の重要な促進要因です。

抗凝固剤の処方率の上昇は、プロトロンビン複合体濃縮物市場の成長をさらに押し上げると予想されます。抗凝固剤は、凝固因子や血小板凝集を阻害することで血栓形成を予防・抑制する物質です。抗凝固薬の処方増加は、主に心血管疾患の有病率の増加、高齢化、幅広い臨床適応、スクリーニングプログラムの改善、抗凝固療法の進歩によってもたらされています。プロトロンビン複合体濃縮物は、過剰な出血を経験した患者や緊急の外科的介入を必要とする患者において、凝固因子を迅速に補充し止血を回復させることで、抗凝固剤の効果を打ち消すのに役立ちます。例えば、2023年11月、英国の政府機関である国民保健サービス（NHS）は、2022年に新たに46万人が抗凝固薬の使用を開始し、2,400万件以上の処方箋が患者に発行されたと報告しました。これにより、推定1万7,000人の脳卒中と4,000人の死亡を防ぐことができました。その結果、抗凝固薬の処方率の増加がプロトロンビン複合体濃縮物市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界プロトロンビン複合体濃縮物PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のプロトロンビン複合体濃縮物市場：成長率分析
• 世界のプロトロンビン複合体濃縮物市場の実績：規模と成長, 2019-2024
• 世界のプロトロンビン複合体濃縮物市場の予測：規模と成長, 2024-2029, 2034F
• 世界プロトロンビン複合体濃縮物総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のプロトロンビン複合体濃縮物市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 3因子プロトロンビン複合体濃縮物
• 4因子プロトロンビン複合体濃縮物
• その他の製品
• 世界のプロトロンビン複合体濃縮物市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 第IX因子欠乏症（血友病B）における出血性エピソード
• トラウマ
• 急性出血を伴う生命を脅かす凝固障害
• ワルファリン関連急性生命を脅かす出血
• 急性出血を伴う非ワルファリン抗凝固薬の拮抗
• 世界のプロトロンビン複合体濃縮物市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈内
• 皮下
• 筋肉内
• 世界のプロトロンビン複合体濃縮物市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院および外来手術センター
• 専門クリニック
• その他のエンドユーザー
• 世界のプロトロンビン複合体濃縮物市場3因子プロトロンビン複合体濃縮物の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低用量3因子プロトロンビン複合体濃縮物（PCC）
• 高用量3因子プロトロンビン複合体濃縮物（PCC）
• 凍結乾燥3因子プロトロンビン複合体濃縮物（PCC）
• 世界のプロトロンビン複合体濃縮物市場4因子プロトロンビン複合体濃縮物の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低用量4因子プロトロンビン複合体濃縮物（PCC）
• 高用量4因子プロトロンビン複合体濃縮物（PCC）
• 活性化4因子プロトロンビン複合体濃縮物（PCC）
• 世界のプロトロンビン複合体濃縮物市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組換え凝固因子複合体
• 血漿由来凝固因子複合体
• 併用療法製品

第7章 地域別・国別分析

• 世界のプロトロンビン複合体濃縮物市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のプロトロンビン複合体濃縮物市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• プロトロンビン複合体濃縮物市場：競合情勢
• プロトロンビン複合体濃縮物市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
  • CSL Behring GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Intas Pharmaceuticals Ltd
• Baxter International Inc
• Grifols S.A.
• Octapharma AG
• Kedrion S.p.A
• Haemonetics Corporation
• Green Cross Corporation
• Shanghai RAAS Blood Products Co. Ltd
• Emergent BioSolutions
• LFB Group
• Hualan Biological Engineering Chongqing Co. Ltd.
• Sanquin Blood Supply Foundation
• Bio Products Laboratory Ltd（BPL）
• Prothya Biosolutions B.V.
• China Biologic Products Holdings Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• プロトロンビン複合体濃縮物市場2029：新たな機会を提供する国
• プロトロンビン複合体濃縮物市場2029：新たな機会を提供するセグメント
• プロトロンビン複合体濃縮物市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Prothrombin complex concentrate (PCC) is a medication that contains clotting factors, used to treat or prevent bleeding in patients with coagulation disorders. It is administered intravenously to quickly restore clotting factor levels in conditions such as hemophilia, warfarin reversal, and severe bleeding episodes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of prothrombin complex concentrate products include 3-factor prothrombin complex concentrates (3F-PCC), 4-factor prothrombin complex concentrates (4F-PCC), and other variations. 3-factor prothrombin complex concentrates (3F-PCC) are blood products containing clotting factors II, IX, and X, used to manage bleeding without the need for factor VII supplementation. These are indicated for conditions such as hemorrhagic episodes in factor IX deficiency (hemophilia B), trauma, life-threatening coagulopathy with acute bleeding, warfarin-associated acute life-threatening bleeding, and non-warfarin anticoagulant reversal during acute bleeding. The routes of administration include intravenous (IV), subcutaneous, and intramuscular injections, with usage in hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

The prothrombin complex concentrate market research report is one of a series of new reports from The Business Research Company that provides prothrombin complex concentrate market statistics, including the prothrombin complex concentrate industry global market size, regional shares, competitors with the prothrombin complex concentrate market share, detailed prothrombin complex concentrate market segments, market trends, and opportunities, and any further data you may need to thrive in the prothrombin complex concentrate industry. This prothrombin complex concentrate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The prothrombin complex concentrate market size has grown strongly in recent years. It will grow from$1.29 billion in 2024 to $1.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth during the historic period can be attributed to factors such as the rising prevalence of bleeding disorders, increased use of PCC in warfarin reversal, greater awareness of coagulation therapies, expansion of surgical procedures, and a higher number of trauma cases.

The prothrombin complex concentrate market size is expected to see strong growth in the next few years. It will grow to$1.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth during the forecast period can be attributed to factors such as the growing demand for rapid coagulation therapies, the increasing prevalence of hemophilia and liver diseases, rising adoption in emergency medicine, expanding applications in cardiac surgeries, and higher healthcare expenditures. Key trends during this period include the integration of AI-driven diagnostics, advancements in recombinant coagulation factors, next-generation recombinant PCCs, customized dosing algorithms, and progress in blood plasma products.

The growing prevalence of bleeding disorders is anticipated to drive the expansion of the prothrombin complex concentrate market in the coming years. Bleeding disorders are conditions in which blood does not clot properly, leading to excessive bleeding due to missing or malfunctioning clotting factors or platelets. The rise in bleeding disorders is mainly attributed to the increasing prevalence of genetic conditions such as hemophilia, more cases of liver diseases, the wider use of anticoagulant medications, and higher rates of vitamin K deficiencies. Prothrombin complex concentrate helps manage bleeding disorders by quickly replenishing the clotting factors essential for blood coagulation and hemostasis. For example, in November 2023, a U.S.-based medical library, the National Library of Medicine, reported a study conducted in 2022 across 87 treatment centers in 40 countries. This study involved 10,276 individuals with hemophilia, with 49% of participants having severe hemophilia. The majority (99%) of the participants were male, and 85% had hemophilia A. Additionally, 67% of the patients were from low- and middle-income countries. Thus, the increasing prevalence of bleeding disorders is a significant driver for the prothrombin complex concentrate market.

The rising prescription rate of anticoagulants is expected to further boost the growth of the prothrombin complex concentrate market. Anticoagulants are substances that prevent or reduce blood clot formation by inhibiting coagulation factors or platelet aggregation. The increased prescription of anticoagulants is primarily driven by the growing prevalence of cardiovascular diseases, an aging population, broader clinical indications, better screening programs, and advancements in anticoagulant therapy. Prothrombin complex concentrate helps counteract the effects of anticoagulants by quickly replenishing clotting factors and restoring hemostasis in patients experiencing excessive bleeding or requiring urgent surgical intervention. For instance, in November 2023, the National Health Service (NHS), a UK-based government body, reported that in 2022, 460,000 additional people began using anticoagulant medications, with over 24 million prescriptions issued to patients. This helped prevent an estimated 17,000 strokes and 4,000 deaths. Consequently, the increasing prescription rate of anticoagulants is contributing to the growth of the prothrombin complex concentrate market.

Leading companies in the prothrombin complex concentrate market are developing innovative formulations, such as lyophilized powder, to improve stability, enhance storage, and simplify administration. The lyophilized powder is a freeze-dried formulation that removes water to extend shelf life while maintaining potency. This enables better storage conditions and rapid reconstitution for emergency use. For example, in July 2023, Octapharma USA Inc., a biotechnology company based in the U.S., received FDA approval for Balfaxar, a four-factor prothrombin complex concentrate (4F-PCC) for the urgent reversal of warfarin during surgeries and invasive procedures. The approval was based on the results from the LEX-209 trial, which demonstrated 94.6% hemostatic efficacy, proving it to be as effective as Kcentra. This development highlights the industry's focus on advancing coagulation therapies to improve patient outcomes in critical care environments.

Major players in the prothrombin complex concentrate market are Pfizer Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, CSL Behring GmbH, Intas Pharmaceuticals Ltd, Baxter International Inc, Grifols S.A., Octapharma AG, Kedrion S.p.A, Haemonetics Corporation, Green Cross Corporation, Shanghai RAAS Blood Products Co. Ltd, Emergent BioSolutions, LFB Group, Hualan Biological Engineering Chongqing Co. Ltd., Sanquin Blood Supply Foundation, Bio Products Laboratory Ltd (BPL), Prothya Biosolutions B.V., and China Biologic Products Holdings Inc.

North America was the largest region in the prothrombin complex concentrate market in 2024. The regions covered in prothrombin complex concentrate report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the prothrombin complex concentrate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prothrombin complex concentrate market consists of sales of activated PCC, recombinant coagulation factors, combination hemostatic agents, warfarin reversal, and emergency coagulation therapy products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prothrombin Complex Concentrate Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prothrombin complex concentrate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prothrombin complex concentrate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prothrombin complex concentrate market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: 3-Factor Prothrombin Complex Concentrates; 4-Factor Prothrombin Complex Concentrates; Other Products
• 2) By Indication: Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B); Trauma; Life-Threatening Coagulopathy With Acute Bleeding; Warfarin-Associated Acute, Life-Threatening Bleeding; Non-Warfarin Anticoagulant Reversal With Acute Bleeding
• 3) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular
• 4) By End-Use: Hospital And Ambulatory Surgical Centers; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Type: Low-Dose 3-Factor Prothrombin Complex Concentrates (PCC); High-Dose 3-Factor Prothrombin Complex Concentrates (PCC); Lyophilized 3-Factor Prothrombin Complex Concentrates (PCC)
• 2) By Type: Low-Dose 4-Factor Prothrombin Complex Concentrates (PCC); High-Dose 4-Factor Prothrombin Complex Concentrates (PCC); Activated 4-Factor Prothrombin Complex Concentrates (PCC)
• 3) By Type: Recombinant Coagulation Factor Complexes; Plasma-Derived Coagulation Factor Complexes; Combination Therapy Products
• Companies Mentioned: Pfizer Inc.; Bristol-Myers Squibb Company; Takeda Pharmaceutical Company Limited; Novo Nordisk A/S; CSL Behring GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prothrombin Complex Concentrate Market Characteristics

3. Prothrombin Complex Concentrate Market Trends And Strategies

4. Prothrombin Complex Concentrate Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Prothrombin Complex Concentrate Growth Analysis And Strategic Analysis Framework

• 5.1. Global Prothrombin Complex Concentrate PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Prothrombin Complex Concentrate Market Growth Rate Analysis
• 5.4. Global Prothrombin Complex Concentrate Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Prothrombin Complex Concentrate Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Prothrombin Complex Concentrate Total Addressable Market (TAM)

6. Prothrombin Complex Concentrate Market Segmentation

• 6.1. Global Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 3-Factor Prothrombin Complex Concentrates
• 4-Factor Prothrombin Complex Concentrates
• Other Products
• 6.2. Global Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B)
• Trauma
• Life-Threatening Coagulopathy With Acute Bleeding
• Warfarin-Associated Acute, Life-Threatening Bleeding
• Non-Warfarin Anticoagulant Reversal With Acute Bleeding
• 6.3. Global Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous
• Subcutaneous
• Intramuscular
• 6.4. Global Prothrombin Complex Concentrate Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital And Ambulatory Surgical Centers
• Specialty Clinics
• Other End Users
• 6.5. Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of 3-Factor Prothrombin Complex Concentrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Dose 3-Factor Prothrombin Complex Concentrates (PCC)
• High-Dose 3-Factor Prothrombin Complex Concentrates (PCC)
• Lyophilized 3-Factor Prothrombin Complex Concentrates (PCC)
• 6.6. Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of 4-Factor Prothrombin Complex Concentrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Dose 4-Factor Prothrombin Complex Concentrates (PCC)
• High-Dose 4-Factor Prothrombin Complex Concentrates (PCC)
• Activated 4-Factor Prothrombin Complex Concentrates (PCC)
• 6.7. Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Coagulation Factor Complexes
• Plasma-Derived Coagulation Factor Complexes
• Combination Therapy Products

7. Prothrombin Complex Concentrate Market Regional And Country Analysis

• 7.1. Global Prothrombin Complex Concentrate Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Prothrombin Complex Concentrate Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prothrombin Complex Concentrate Market

• 8.1. Asia-Pacific Prothrombin Complex Concentrate Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prothrombin Complex Concentrate Market

• 9.1. China Prothrombin Complex Concentrate Market Overview
• 9.2. China Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prothrombin Complex Concentrate Market

• 10.1. India Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prothrombin Complex Concentrate Market

• 11.1. Japan Prothrombin Complex Concentrate Market Overview
• 11.2. Japan Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prothrombin Complex Concentrate Market

• 12.1. Australia Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prothrombin Complex Concentrate Market

• 13.1. Indonesia Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prothrombin Complex Concentrate Market

• 14.1. South Korea Prothrombin Complex Concentrate Market Overview
• 14.2. South Korea Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prothrombin Complex Concentrate Market

• 15.1. Western Europe Prothrombin Complex Concentrate Market Overview
• 15.2. Western Europe Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prothrombin Complex Concentrate Market

• 16.1. UK Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prothrombin Complex Concentrate Market

• 17.1. Germany Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prothrombin Complex Concentrate Market

• 18.1. France Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prothrombin Complex Concentrate Market

• 19.1. Italy Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prothrombin Complex Concentrate Market

• 20.1. Spain Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prothrombin Complex Concentrate Market

• 21.1. Eastern Europe Prothrombin Complex Concentrate Market Overview
• 21.2. Eastern Europe Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prothrombin Complex Concentrate Market

• 22.1. Russia Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prothrombin Complex Concentrate Market

• 23.1. North America Prothrombin Complex Concentrate Market Overview
• 23.2. North America Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prothrombin Complex Concentrate Market

• 24.1. USA Prothrombin Complex Concentrate Market Overview
• 24.2. USA Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prothrombin Complex Concentrate Market

• 25.1. Canada Prothrombin Complex Concentrate Market Overview
• 25.2. Canada Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prothrombin Complex Concentrate Market

• 26.1. South America Prothrombin Complex Concentrate Market Overview
• 26.2. South America Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prothrombin Complex Concentrate Market

• 27.1. Brazil Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prothrombin Complex Concentrate Market

• 28.1. Middle East Prothrombin Complex Concentrate Market Overview
• 28.2. Middle East Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prothrombin Complex Concentrate Market

• 29.1. Africa Prothrombin Complex Concentrate Market Overview
• 29.2. Africa Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prothrombin Complex Concentrate Market Competitive Landscape And Company Profiles

• 30.1. Prothrombin Complex Concentrate Market Competitive Landscape
• 30.2. Prothrombin Complex Concentrate Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CSL Behring GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Prothrombin Complex Concentrate Market Other Major And Innovative Companies

• 31.1. Intas Pharmaceuticals Ltd
• 31.2. Baxter International Inc
• 31.3. Grifols S.A.
• 31.4. Octapharma AG
• 31.5. Kedrion S.p.A
• 31.6. Haemonetics Corporation
• 31.7. Green Cross Corporation
• 31.8. Shanghai RAAS Blood Products Co. Ltd
• 31.9. Emergent BioSolutions
• 31.10. LFB Group
• 31.11. Hualan Biological Engineering Chongqing Co. Ltd.
• 31.12. Sanquin Blood Supply Foundation
• 31.13. Bio Products Laboratory Ltd (BPL)
• 31.14. Prothya Biosolutions B.V.
• 31.15. China Biologic Products Holdings Inc

32. Global Prothrombin Complex Concentrate Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prothrombin Complex Concentrate Market

34. Recent Developments In The Prothrombin Complex Concentrate Market

35. Prothrombin Complex Concentrate Market High Potential Countries, Segments and Strategies

• 35.1 Prothrombin Complex Concentrate Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Prothrombin Complex Concentrate Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Prothrombin Complex Concentrate Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34940_Prothrombin_Complex_Concentrate_GMR_2025